Scientific illustration of a liposome with visible phospholipid bilayer and enzyme molecules inside, on a dark blue background

The world's first enzyme supplement developed for alcohol intolerance

Alcolase is developing a liposomal enzyme system designed to break down alcohol in the stomach before it reaches the bloodstream.

540 million

people worldwide carry an ALDH2 deficiency that makes drinking alcohol painful, embarrassing, and potentially dangerous. There is no effective solution on the market. We are building one.

How it works

Take before drinking

A supplement taken before drinking delivers three enzymes to your stomach, protected inside liposomes.

Illustration of liposome spheres dispersing from a central point

Enzymes target alcohol in the stomach

The enzymes are designed to convert ethanol into harmless byproducts inside the stomach, before alcohol is absorbed into the bloodstream.

Illustration of a liposome cross-section showing enzymes inside and ethanol molecules passing through the membrane

A science-first approach

Designed to work with your body's own alcohol metabolism, using enzymes to support the breakdown of alcohol and acetaldehyde in the stomach.

Illustration showing amber ethanol molecules transforming into blue acetate molecules

Backed by

Ada Ventures logo
Delphinus Venture Capital logo
Antler logo

We are a Copenhagen-based biotech developing enzyme delivery technology for the 540 million people affected by alcohol intolerance, with initial markets in Singapore and South Korea.